Share-based Payment Arrangement, Expense in USD of Gossamer Bio, Inc. from 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Gossamer Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2017 to Q3 2025.
  • Gossamer Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $2.67M, a 44.9% decline year-over-year.
  • Gossamer Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $12.6M, a 54.6% decline year-over-year.
  • Gossamer Bio, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $20.6M, a 27.7% decline from 2023.
  • Gossamer Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $28.5M, a 33% decline from 2022.
  • Gossamer Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $42.6M, a 32.9% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Gossamer Bio, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $12.6M $2.67M -$2.18M -44.9% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 $14.8M $2.59M -$2.42M -48.3% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025
Q1 2025 $17.2M $2.41M -$3.41M -58.6% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $20.6M $4.97M -$7.19M -59.2% 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025
Q3 2024 $27.8M $4.84M -$1.32M -21.4% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025
Q2 2024 $29.1M $5M -$3.2M -39% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025
Q1 2024 $32.3M $5.81M +$3.81M +191% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 $28.5M $12.2M +$710K +6.2% 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025
Q3 2023 $27.8M $6.16M -$3.96M -39.1% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 $31.8M $8.2M -$1.8M -18% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024
Q1 2023 $2M -$8.98M -81.8% 05 May 2023 10-K 13 Mar 2025
Q1 2023 $33.6M $8.13M -$2.86M -26% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024
Q4 2022 $42.6M $11.4M +$3.79M +49.5% 01 Oct 2022 31 Dec 2022 10-K 13 Mar 2025
Q3 2022 $38.8M $10.1M +$2.54M +33.4% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $36.2M $10M +$1.95M +24.1% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 $34.3M $11M +$2.28M +26.1% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 $32M $7.66M -$5.02M -39.6% 01 Oct 2021 31 Dec 2021 10-K 05 Mar 2024
Q3 2021 $37M $7.59M -$1.34M -15% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 $38.4M $8.05M -$846K -9.51% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 $39.2M $8.71M +$464K +5.63% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022
Q4 2020 $38.7M $12.7M +$5.82M +84.8% 01 Oct 2020 31 Dec 2020 10-K 17 Mar 2023
Q3 2020 $32.9M $8.92M +$3.2M +55.8% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021
Q2 2020 $29.7M $8.9M +$3.76M +73.2% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021
Q1 2020 $26M $8.24M +$5.16M +167% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q4 2019 $20.8M $6.86M -$3.94M -36.5% 01 Oct 2019 31 Dec 2019 10-K 03 Mar 2022
Q3 2019 $24.8M $5.73M -$12.4M -68.5% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020
Q2 2019 $37.2M $5.14M +$3.77M +274% 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020
Q1 2019 $33.4M $3.09M +$2.48M +411% 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020
Q4 2018 $30.9M $10.8M 01 Oct 2018 31 Dec 2018 10-K 26 Feb 2021
Q3 2018 $18.2M 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 $1.37M 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019
Q1 2018 $605K 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019

Gossamer Bio, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $20.6M -$7.9M -27.7% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025
2023 $28.5M -$14M -33% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025
2022 $42.6M +$10.5M +32.9% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2025
2021 $32M -$6.74M -17.4% 01 Jan 2021 31 Dec 2021 10-K 05 Mar 2024
2020 $38.7M +$17.9M +86.1% 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2023
2019 $20.8M -$10.1M -32.7% 01 Jan 2019 31 Dec 2019 10-K 03 Mar 2022
2018 $30.9M +$30.9M +96609% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021
2017 $32K 01 Jan 2017 31 Dec 2017 10-K 24 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.